US Stock MarketDetailed Quotes

Actuate Therapeutics (ACTU)

Watchlist
  • 2.620
  • -0.280-9.66%
Close May 15 16:00 ET
  • 2.620
  • 0.0000.00%
Post 19:43 ET
62.69MMarket Cap-2.67P/E (TTM)

Actuate Therapeutics (ACTU) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
109.13%8.13M
52.28%13.16M
52.28%13.16M
25.15%16.92M
1,746.03%6.49M
88.05%3.89M
192.08%8.64M
192.08%8.64M
--13.52M
--351.71K
-Cash and cash equivalents
109.13%8.13M
52.28%13.16M
52.28%13.16M
25.15%16.92M
1,746.03%6.49M
88.05%3.89M
192.08%8.64M
192.08%8.64M
--13.52M
--351.71K
Other current assets
7.32%385.44K
-14.53%484K
-14.53%484K
-29.77%519.24K
-1.05%195.9K
199.86%359.16K
1,434.34%566.28K
1,434.34%566.28K
--739.33K
--197.98K
Total current assets
100.53%8.52M
48.17%13.64M
48.17%13.64M
22.30%17.44M
1,116.79%6.69M
94.17%4.25M
207.38%9.21M
207.38%9.21M
--14.26M
--549.69K
Non current assets
Non current deferred assets
----
----
----
----
-76.27%280.34K
-54.07%234.48K
----
----
----
--1.18M
Other non current assets
--391.84K
255.04%392.49K
255.04%392.49K
--269.93K
----
----
--110.55K
--110.55K
----
----
Total non current assets
67.11%391.84K
255.04%392.49K
255.04%392.49K
--269.93K
-76.27%280.34K
-54.07%234.48K
--110.55K
--110.55K
--0
--1.18M
Total assets
98.78%8.91M
50.62%14.04M
50.62%14.04M
24.20%17.71M
302.63%6.97M
66.13%4.48M
211.07%9.32M
211.07%9.32M
--14.26M
--1.73M
Liabilities
Current liabilities
Payables
-54.57%1.2M
-20.66%1.52M
-20.66%1.52M
-46.55%1.25M
-46.19%3.17M
-33.16%2.64M
-43.86%1.92M
-43.86%1.92M
--2.33M
--5.89M
-accounts payable
-54.57%1.2M
-20.66%1.52M
-20.66%1.52M
-46.55%1.25M
-46.19%3.17M
-33.16%2.64M
-43.86%1.92M
-43.86%1.92M
--2.33M
--5.89M
Current accrued expenses
-50.02%2.63M
-40.02%3.59M
-40.02%3.59M
-30.59%4.28M
-33.71%4.64M
-4.16%5.27M
86.04%5.99M
86.04%5.99M
--6.17M
--7M
Current debt and capital lease obligation
----
----
----
----
----
----
----
----
----
--6.9M
-Current debt
----
----
----
----
----
----
----
----
----
--6.9M
Current liabilities
-48.42%4.72M
-35.17%5.71M
-35.17%5.71M
-25.00%6.37M
-54.16%9.2M
-37.87%9.15M
27.19%8.8M
27.19%8.8M
--8.5M
--20.07M
Non current liabilities
Non current accrued expenses
----
--0
--0
--0
-75.90%16.89K
-91.24%11.83K
-94.80%6.77K
-94.80%6.77K
--1.69K
--70.1K
Derivative product liabilities
----
----
----
----
----
----
--0
--0
--0
--1.26M
Preferred securities outside stock equity
----
----
----
----
----
----
--0
--0
--0
--94.18M
Total non current liabilities
-2.84%404.99K
-1.64%404.99K
-1.64%404.99K
-0.42%404.99K
-99.56%421.88K
-99.56%416.82K
-99.57%411.76K
-99.57%411.76K
--406.68K
--95.91M
Total liabilities
-46.43%5.13M
-33.67%6.11M
-33.67%6.11M
-23.88%6.78M
-91.70%9.62M
-91.34%9.57M
-91.02%9.21M
-91.02%9.21M
--8.9M
--115.99M
Shareholders'equity
Share capital
20.00%24
15.00%23
15.00%23
15.00%23
900.00%20
900.00%20
900.00%20
900.00%20
--20
--2
-common stock
20.00%24
15.00%23
15.00%23
15.00%23
900.00%20
900.00%20
900.00%20
900.00%20
--20
--2
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
----
----
Retained earnings
-15.53%-160.23M
-16.79%-154.61M
-16.79%-154.61M
-19.15%-150.05M
-20.58%-144.65M
-22.32%-138.7M
-25.96%-132.38M
-25.96%-132.38M
---125.93M
---119.96M
Paid-in capital
22.76%164.02M
22.68%162.53M
22.68%162.53M
22.62%160.99M
2,388.38%141.99M
2,278.99%133.61M
2,322.89%132.48M
2,322.89%132.48M
--131.29M
--5.71M
Total stockholders'equity
174.38%3.78M
7,505.63%7.92M
7,505.63%7.92M
104.09%10.94M
97.68%-2.65M
95.28%-5.09M
100.10%104.19K
100.10%104.19K
--5.36M
---114.26M
Total equity
174.38%3.78M
7,505.63%7.92M
7,505.63%7.92M
104.09%10.94M
97.68%-2.65M
95.28%-5.09M
100.10%104.19K
100.10%104.19K
--5.36M
---114.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 109.13%8.13M52.28%13.16M52.28%13.16M25.15%16.92M1,746.03%6.49M88.05%3.89M192.08%8.64M192.08%8.64M--13.52M--351.71K
-Cash and cash equivalents 109.13%8.13M52.28%13.16M52.28%13.16M25.15%16.92M1,746.03%6.49M88.05%3.89M192.08%8.64M192.08%8.64M--13.52M--351.71K
Other current assets 7.32%385.44K-14.53%484K-14.53%484K-29.77%519.24K-1.05%195.9K199.86%359.16K1,434.34%566.28K1,434.34%566.28K--739.33K--197.98K
Total current assets 100.53%8.52M48.17%13.64M48.17%13.64M22.30%17.44M1,116.79%6.69M94.17%4.25M207.38%9.21M207.38%9.21M--14.26M--549.69K
Non current assets
Non current deferred assets -----------------76.27%280.34K-54.07%234.48K--------------1.18M
Other non current assets --391.84K255.04%392.49K255.04%392.49K--269.93K----------110.55K--110.55K--------
Total non current assets 67.11%391.84K255.04%392.49K255.04%392.49K--269.93K-76.27%280.34K-54.07%234.48K--110.55K--110.55K--0--1.18M
Total assets 98.78%8.91M50.62%14.04M50.62%14.04M24.20%17.71M302.63%6.97M66.13%4.48M211.07%9.32M211.07%9.32M--14.26M--1.73M
Liabilities
Current liabilities
Payables -54.57%1.2M-20.66%1.52M-20.66%1.52M-46.55%1.25M-46.19%3.17M-33.16%2.64M-43.86%1.92M-43.86%1.92M--2.33M--5.89M
-accounts payable -54.57%1.2M-20.66%1.52M-20.66%1.52M-46.55%1.25M-46.19%3.17M-33.16%2.64M-43.86%1.92M-43.86%1.92M--2.33M--5.89M
Current accrued expenses -50.02%2.63M-40.02%3.59M-40.02%3.59M-30.59%4.28M-33.71%4.64M-4.16%5.27M86.04%5.99M86.04%5.99M--6.17M--7M
Current debt and capital lease obligation --------------------------------------6.9M
-Current debt --------------------------------------6.9M
Current liabilities -48.42%4.72M-35.17%5.71M-35.17%5.71M-25.00%6.37M-54.16%9.2M-37.87%9.15M27.19%8.8M27.19%8.8M--8.5M--20.07M
Non current liabilities
Non current accrued expenses ------0--0--0-75.90%16.89K-91.24%11.83K-94.80%6.77K-94.80%6.77K--1.69K--70.1K
Derivative product liabilities --------------------------0--0--0--1.26M
Preferred securities outside stock equity --------------------------0--0--0--94.18M
Total non current liabilities -2.84%404.99K-1.64%404.99K-1.64%404.99K-0.42%404.99K-99.56%421.88K-99.56%416.82K-99.57%411.76K-99.57%411.76K--406.68K--95.91M
Total liabilities -46.43%5.13M-33.67%6.11M-33.67%6.11M-23.88%6.78M-91.70%9.62M-91.34%9.57M-91.02%9.21M-91.02%9.21M--8.9M--115.99M
Shareholders'equity
Share capital 20.00%2415.00%2315.00%2315.00%23900.00%20900.00%20900.00%20900.00%20--20--2
-common stock 20.00%2415.00%2315.00%2315.00%23900.00%20900.00%20900.00%20900.00%20--20--2
-Preferred stock --0--0--0--0--0--0--0--0--------
Retained earnings -15.53%-160.23M-16.79%-154.61M-16.79%-154.61M-19.15%-150.05M-20.58%-144.65M-22.32%-138.7M-25.96%-132.38M-25.96%-132.38M---125.93M---119.96M
Paid-in capital 22.76%164.02M22.68%162.53M22.68%162.53M22.62%160.99M2,388.38%141.99M2,278.99%133.61M2,322.89%132.48M2,322.89%132.48M--131.29M--5.71M
Total stockholders'equity 174.38%3.78M7,505.63%7.92M7,505.63%7.92M104.09%10.94M97.68%-2.65M95.28%-5.09M100.10%104.19K100.10%104.19K--5.36M---114.26M
Total equity 174.38%3.78M7,505.63%7.92M7,505.63%7.92M104.09%10.94M97.68%-2.65M95.28%-5.09M100.10%104.19K100.10%104.19K--5.36M---114.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More